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background:  Atrial fibrillation (AF) is considered to be associated with poor clinical outcomes in patients with acute myocardial infarction 
(AMI). However, it remains uncertain whether transient new-onset AF during AMI have an increased risk of clinical outcomes. We 
investigated the prognostic implications of transient new-onset AF in AMI patients.
methods:  The study population included 2,171 consecutive AMI patients. Transient new-onset AF was defined as AF that developed 
during AMI without the prior history and was not documented after hospital discharge. The primary endpoint, major adverse cardiac events 
(MACE), was defined as death, AMI, target vessel revascularization, heart failure requiring admission, and cerebrovascular events.
Results:  Overall, AF was observed in 214 patients (9.9%). Transient new-onset AF occurred in 103 (4.7%) among 154 patients (7.0%) 
who had new-onset AF after AMI. Patients with transient new-onset AF were older (69±13 vs. 63±13 yrs, p<0.001) and more likely to be 
female (37 vs. 26%, p=0.018) than those without AF. Patients with transient new-onset AF exhibited faster heart rate (107±36 vs. 79±19 
beats/min, p<0.001) and lower systolic (118±34 vs. 133±31 mmHg, p=0.012) and diastolic blood pressure (70±21 vs. 78±18 mmHg, 
p=0.025), and showed lower left ventricular ejection fraction (LVEF, 43±15 vs. 49±13%, p<0.001) than those without AF. Cardiogenic 
shock (29 vs. 13%, p<0.001), STEMI (59 vs. 46%, p=0.007), baseline renal dysfunction (eGFR <60, 54 vs. 24%, p<0.001), and systolic 
dysfunction (LVEF <40%, 44 vs. 25%, p<0.001)were also observed more frequently in the transient new-onset AF group. Patients with 
transient new-onset AF presented higher in-hospital mortality compared to those without AF (15.5 vs. 5.1%, p<0.001). The 1-month MACE 
(21.2 vs. 7.1%, p<0.001) and mortality (16.2 vs. 5.4%, p<0.001) rates were higher in the transient AF group compared to the group without 
AF. The 4-year MACE (31.3 vs. 21.6%, p=0.024) and mortality (24.2 vs. 10.7%, p<0.001) rates were also significantly higher in patients 
with transient new-onset AF.
conclusion:  Transient new-onset AF was associated with the both poor short- and long-term clinical outcomes in AMI patients.
